SCHEMBL5247142

SCHEMBL5247142

CC(O)C(=O)OCC1CO1

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
MGLL Q99685 2/20 0.38
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL29196956 0.87 ALDH1A1 (0.42) ALDH1A1TP53CYP3A4MGLL
SCHEMBL16687820 0.85 ALDH1A1 (0.55) ALDH1A1TP53CYP3A4MGLLTSHR
SCHEMBL92977 0.85 ALDH1A1 (0.55) ALDH1A1TP53CYP3A4MGLLTSHR
Hexanoate SCHEMBL29196953 0.83 AKR1B1 (0.46) ALDH1A1TSHR
SCHEMBL8750994 0.83 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MGLLTSHR
Octanoic Acid SCHEMBL29196960 0.82 GPR84 (0.47) ALDH1A1TSHR
Heptanoate SCHEMBL29197332 0.82 GPR84 (0.47) ALDH1A1TSHR
SCHEMBL25268181 0.82 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MGLL
SCHEMBL14198750 0.82 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MGLLTSHR
SCHEMBL12897815 0.82 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MGLLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119143698-A Treatment method of glycidyl methacrylate byproduct tar 万华化学集团股份有限公司 2024-12-17 CN claimed
CN-116284713-A Acetylated lactate flame retardant plasticizer containing phosphaphenanthrene group, and preparation method and application thereof 常州大学 2023-06-23 CN claimed
EP-1527064-B1 PREPARATION OF LACTIC ACID DERIVATIVES AND THEIR USE AROMAGEN CORP (US) 2007-09-12 EP claimed
US-7211693-B2 Preparation of lactic acid derivatives and their use AROMAGEN CORPORATION (US) 2007-05-01 US claimed
US-20060105002-A1 Preparation of lactic acid derivatives and their use AROMAGEN CORPORATION 2006-05-18 US claimed
EP-1527064-A2 PREPARATION OF LACTIC ACID DERIVATIVES AND THEIR USE Aromagen Corporation (US) 2005-05-04 EP claimed
WO-2004013121-A2 PREPARATION OF LACTIC ACID DERIVATIVES AND THEIR USE AROMAGEN CORPORATION (US) 2004-02-12 WO claimed
CN-121058788-A Preparation process of baked pet food 杭州好氏宠物食品有限公司 2025-12-05 CN disclosed
CN-116284713-B Acetylated lactate flame retardant plasticizer containing phosphaphenanthrene group, and preparation method and application thereof 常州大学 2025-05-06 CN disclosed
CN-119143698-A Treatment method of glycidyl methacrylate byproduct tar 万华化学集团股份有限公司 2024-12-17 CN disclosed
CN-119143698-A Treatment method of glycidyl methacrylate byproduct tar 万华化学集团股份有限公司 2024-12-17 CN disclosed
CN-116284713-A Acetylated lactate flame retardant plasticizer containing phosphaphenanthrene group, and preparation method and application thereof 常州大学 2023-06-23 CN disclosed
EP-1527064-B1 PREPARATION OF LACTIC ACID DERIVATIVES AND THEIR USE AROMAGEN CORP (US) 2007-09-12 EP disclosed
US-7211693-B2 Preparation of lactic acid derivatives and their use AROMAGEN CORPORATION (US) 2007-05-01 US disclosed
US-20060105002-A1 Preparation of lactic acid derivatives and their use AROMAGEN CORPORATION 2006-05-18 US disclosed
EP-1527064-A2 PREPARATION OF LACTIC ACID DERIVATIVES AND THEIR USE Aromagen Corporation (US) 2005-05-04 EP disclosed
WO-2004013121-A2 PREPARATION OF LACTIC ACID DERIVATIVES AND THEIR USE AROMAGEN CORPORATION (US) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060105002-A1 Preparation of lactic acid derivatives and their use LDHA, LDHB, SORD ALDH1A1 70/4885TP53 1871/4885CYP3A4 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.